Management of Cyclic Vomiting Syndrome
For prophylaxis in moderate-severe CVS (≥4 episodes/year lasting >2 days with ED visits), start tricyclic antidepressants as first-line therapy; for acute episodes, use combination abortive therapy with sumatriptan plus ondansetron at the earliest prodromal symptoms. 1
Prophylactic Management
When to Start Prophylaxis
Prophylactic therapy is indicated for moderate-severe CVS, defined as:
- ≥4 episodes per year
- Each episode lasting >2 days
- Requiring at least 1 ED visit or hospitalization 1
Patients with mild CVS (<4 episodes/year, <2 days duration, no ED visits) may not require prophylaxis.
First-Line Prophylactic Therapy
Tricyclic antidepressants (TCAs) are strongly recommended as first-line prophylaxis 1, 2. Amitriptyline is the most commonly used TCA, though the guidelines don't specify exact dosing in the provided evidence. TCAs work by modulating central pain pathways and have antimigraine properties, addressing the CNS origin of CVS 3.
Second-Line Prophylactic Options
When TCAs fail or are contraindicated, use these alternatives 1:
- Topiramate (anticonvulsant)
- Aprepitant (NK-1 receptor antagonist)
- Zonisamide (anticonvulsant)
- Levetiracetam (anticonvulsant)
Lifestyle Modifications (Essential for All Patients)
All patients must implement these non-pharmacologic strategies 1:
- Regular sleep schedule (avoid sleep deprivation)
- Avoid prolonged fasting
- Stress management techniques (cognitive behavioral therapy, mindfulness meditation)
- Identify and avoid individual triggers (stress, menstrual cycle, infections, travel, intense exercise)
Comorbidity Management
Treat associated conditions aggressively, as this substantially improves CVS outcomes 1:
- Anxiety/depression (50-60% of patients) - pharmacologic and/or psychotherapy
- Migraine headaches (20-30% of patients)
- Postural orthostatic tachycardia syndrome
- Sleep disorders
- Substance use
Acute/Abortive Management
Timing is Critical
Abortive therapy must be administered during the prodromal phase (early warning symptoms) for maximum effectiveness 1. Educate patients to recognize their specific prodromal symptoms (sense of doom, panic, fatigue, mental fog, anxiety, abdominal discomfort) and act immediately.
First-Line Abortive Therapy
Most patients require combination therapy with 2 agents 1:
Primary combination:
- Sumatriptan (triptan): 6 mg subcutaneously or nasal spray (can repeat once after 2 hours, max 2 doses/24 hours) 1
- Contraindications: ischemic heart disease, stroke, peripheral vascular disease, uncontrolled hypertension, pregnancy
- Nasal spray should be administered head-forward to optimize anterior nasal receptor contact
PLUS
- Ondansetron (5-HT3 antagonist): 8 mg sublingual every 4-6 hours 1
- Obtain baseline ECG (can prolong QTc)
- Sublingual form improves absorption during active vomiting
Alternative Antiemetics (if ondansetron insufficient)
- Promethazine: 12.5-25 mg PO/PR every 4-6 hours (also provides sedation) 1
- Caution: peripheral IV can cause tissue injury/gangrene
- Prochlorperazine: 5-10 mg every 6-8 hours or 25 mg suppository every 12 hours 1
Sedation Strategy
Inducing sedation is often effective for aborting episodes 1. Add sedating agents to the abortive cocktail:
- Alprazolam: 0.5-2 mg every 4-6 hours (sublingual or rectal forms available) 1
- Lorazepam: similar dosing
- Diphenhydramine: 12.5-25 mg every 4-6 hours 1
- Promethazine (dual antiemetic/sedative effect)
Non-Pharmacologic Abortive Measures
- Hot water bathing/showering targeting trunk/back provides temporary relief (present in 48% of CVS patients, not specific to cannabinoid hyperemesis) 1
- Reduce external stimuli: quiet, dark room 4
- Topical capsaicin cream 4
Emergency Department Management
When to Present to ED
- Home abortive therapy fails
- Unable to tolerate oral/sublingual/rectal medications
- Severe dehydration
- Episodes lasting >24 hours 1
ED Treatment Protocol
All patients should have an individualized ED treatment plan shared with their care team 1, 2. This prevents stigmatization and ensures consistent, effective care.
Standard ED approach:
- IV fluids with 10% dextrose (not just normal saline) 5, 6
- IV ondansetron for antiemesis
- IV sedation (lorazepam, diphenhydramine, or antipsychotics like droperidol/haloperidol for refractory cases) 1
- Analgesics for abdominal pain
- Quiet, dark room with minimal stimulation
Recovery Phase Management
After vomiting subsides 1:
- Electrolyte-rich fluids (sports drinks)
- Nutrient drinks
- Recovery typically lasts 1-2 days
- Patients may have residual nausea but can tolerate liquids
Critical Pitfalls to Avoid
Don't delay abortive therapy - waiting until full emetic phase drastically reduces effectiveness 1
Don't mistake hot water bathing as diagnostic of cannabinoid hyperemesis - 48% of non-cannabis users with CVS also exhibit this behavior 1
Don't use monotherapy for acute episodes - combination therapy is nearly always required 1
Don't perform repeated upper GI imaging/endoscopy - one-time evaluation is sufficient to exclude obstruction 1
Don't order routine gastric emptying scans - results during episodes are uninterpretable, and cannabis/opiates confound results 1
Don't stigmatize cannabis users - treat all patients presenting with vomiting regardless of cannabis use concerns 1
Don't ignore comorbidities - treating anxiety, depression, and migraines substantially improves CVS control 1
Cannabis Considerations
Cannabinoid hyperemesis syndrome (CHS) may be a CVS subset when: